California chia

California Chia (Salvia columbariae Benth.)

1. Identity and Botanical Classification

California chia is the common name most widely applied to Salvia columbariae Benth., an annual herbaceous plant in the family Lamiaceae (the mint family). It is also called chia, chia sage, golden chia, or desert chia, because its seeds are used in the same way as those of Salvia hispanica. Additional vernacular names in use include Blue Desert Dagga and, in indigenous languages, Pashí in Tongva and It'epeš in Ventureño.

S. columbariae grows in California, Nevada, Utah, Arizona, New Mexico, Sonora, and Baja California, and was an important food for Native Americans. California chia grows at a greater range of altitude — from sea level to 7,000 feet (2,100 m) — than any other species in the Salvia genus in California.

The plant itself is a short annual. It grows 10 to 50 cm (3.9 to 19.7 in) tall. Its stem hairs are generally short and sparse. It has oblong-ovate basal leaves that are 2 to 10 cm (0.79 to 3.94 in) long, pinnately dissected, with irregularly rounded lobes. The distinctive capitate verticils — head-like clusters of whorls — and blue flowers help to identify this annual plant, which typically blooms from March through July.

1.1 Relationship to Commercial Chia (Salvia hispanica)

The term "chia" encompasses more than one species. Salvia hispanica, the most commercially prominent chia, is a species of flowering plant in the mint family, Lamiaceae, native to central and southern Mexico and Guatemala. It is one of two plants commonly known as "chia," and the word itself originates in Mesoamerica, derived from the Nahuatl word "chian," meaning oily. Salvia columbariae, commonly known as golden chia and California chia, is a herbaceous annual species which also produces edible seed, and has received attention as a new source of semidrying oil.

Because S. columbariae and S. hispanica are closely related members of the same genus and family, and because the seeds of both are used interchangeably as food, scientific literature on the nutritional composition and clinical evidence for chia seeds applies broadly to both species. The majority of modern clinical, nutritional, and pharmacological research has been conducted on S. hispanica; the ethnobotanical record, however, is especially rich for S. columbariae in the context of the indigenous peoples of California, the Sonoran Desert, and the American Southwest. This article covers both where evidence is available, clearly distinguishing between them.

1.2 Nomenclatural History

The name hispanica, meaning "of Spain," reflects a botanical error of long standing. When Linnaeus gave the species the name hispanica, he appears to have repeated the error of an earlier author who described it as "Spanisch Sharlach" in a European herbal. Neither that author nor Linnaeus seems to have realized that the plant was not a Spanish or even a European native, and no one seemed aware that it was an important food plant from Mexico, known as Chia. The correct author citation is therefore Salvia hispanica L. for the commercial species, and Salvia columbariae Benth. for California chia. The epithet "columbariae" is derived from a Latin word meaning "dove-like."

1.3 Common Forms and Preparations

California chia seeds are the primary form used historically and in contemporary natural food markets. Seeds may be consumed:

• Whole, dry: Ground or whole seeds sprinkled over foods or taken with water.
• Soaked/gel form: The seeds are hygroscopic, absorbing up to 12 times their weight in liquid when soaked and developing a mucilaginous coating that gives chia-based foods and beverages a distinctive gel texture.
• Ground into flour or meal: Chia seeds were roasted and ground into flour, and used as the basis of a beverage known as chianatolli in Aztec tradition.
• Pressed for oil: Historically, the seed was used in medicine, ground into flour, mixed as an ingredient in drinks, and pressed for oil.
• Poultice: Used externally in several Native American traditions (see Section 2 below).
• As a beverage additive: The Cahuilla, Kawaiisu, Mohave, Tohono O'odham, Chumash, and Akimel O'odham grind the seeds and mix them into water to make a thick beverage.

2. Traditional and Historical Use

2.1 Pre-Columbian Mesoamerica (Salvia hispanica)

The archaeological and textual record for chia is among the richest for any pre-Columbian food crop. Salvia hispanica has served as a food source for Mesoamerican populations at least since 3,500 BC. There is evidence that the crop was widely cultivated by the Aztecs in pre-Columbian times and was a staple food for Mesoamerican cultures, with a second and separate area of cultivation, apparently pre-Columbian, in southern Honduras and Nicaragua.

Chia seeds served as a staple food for the Nahuatl (Aztec) cultures and may have been as important as maize as a food crop. Jesuit chroniclers placed chia as the third-most important crop in the Aztec culture, behind only corn and beans, and ahead of amaranth. The importance of these four crops in Aztec diets is supported by codices written around the time of the conquest of America, including the Florentine Codex, written between 1548 and 1585 by Fray Bernardino de Sahagún, titled the General History of the Things of New Spain — an entire twelve-volume work written in Nahuatl and Spanish, now held in the Medicca Laurentziana library in Florence, Italy.

The Florentine Codex mentions two main varieties: the smaller "black" ayauhchien seed, used as a lacquer, and the thicker, "white" and "wrinkled" chientzotzol seed, commonly used in preparing a refreshing drink.

Multiple preparation methods are documented. The ancient indigenous Aztec civilization consumed chia seed roasted and ground, incorporated into many foods as a source of energy. During the time of the Aztecs, roasted chia seed was mixed with amaranth seed, corn flour, and maguey syrup to form a dough called tzoalli in the Nahuatl language, eaten routinely and ceremonially, and still consumed. The ancient Aztecs processed the seeds for beverages and extracted oils for use in medicines and many other applications; chia was used to relieve gastrointestinal distress and to treat eye infections. Chia seed oil was also commonly used as the base for ceremonial body paint.

Chia held ceremonial and economic importance beyond daily nutrition. Chia was very important to the Aztecs both ceremonially and economically; it was believed to have been given to the Aztecs by the goddess Chicome Coatl, the creator of life, and was offered at her pyramid with corn, beans, and amaranth. Every year, as documented by the Codex Mendoza (written between 1541 and 1542), the Aztec empire, especially the city of Tenochtitlan, received thousands of tons of tribute from surrounding peoples in the form of chia, corn, beans, and amaranth.

Many crops that held a major role in pre-Columbian American diets were banned by the Spanish because of their close association with religion, and were replaced by foreign species such as wheat, barley, and carrots, which were in demand in Europe. Cultivation and use of chia declined sharply following the Spanish conquest, and the crop was largely absent from mainstream agriculture for centuries.

2.2 Indigenous California and the American Southwest (Salvia columbariae)

Salvia columbariae — the California chia — was a foundational food plant for a wide array of indigenous peoples across California, Nevada, Arizona, and adjacent regions. The Chumash Indians of the Santa Barbara area used chia seeds as a major food, constantly mentioned by Harrington's Chumash consultants and many other historical sources; the seeds also had medicinal uses.

The Cahuilla Indians of the Colorado Desert, the San Bernardino, and San Jacinto Mountains practiced plant management by periodically burning over chia stands to facilitate the next season's growth. Across many tribes, food preparations showed considerable diversity:

• The Cahuilla, Kawaiisu, Mohave, Tohono O'odham, Chumash, and Akimel O'odham ground the seeds and mixed them into water to make a thick beverage; the Cahuilla removed alkali salts from the water to improve flavor, and also dried the seeds to make cakes or mush.
• The Ohlone, Mohave, and Pomo made pinole.
• The Mahuna, Paiute, and Akimel O'odham made it into a gelatinous material, then cooked it into porridge.
• The Kumeyaay added the seeds to wheat to improve flavor.
• Chumash would toast the seeds and grind them to a paste, before incorporating them into their meals or drinks.
• Chia seeds were especially used by Chumash messengers (ksen), who ran perhaps 30 km or more in a day delivering messages between villages.

Medicinal uses across tribes were diverse and well-documented:

• The Cahuilla used S. columbariae as a disinfectant by grinding the seeds to mush and applying it to infections as a poultice.
• The Cahuilla, Ohlone, Kawaiisu, and Mahuna used the gelatinous seeds to cleanse out foreign matter in the eyes; seeds were placed in the eyes for infections and inflammation, and during sleep they were tucked underneath the eyelids to remove sand particles.
• The Ohlone used the seeds to reduce fevers by consuming them, and the Kumeyaay chewed the seeds on journeys by foot to give strength.
• The seed was used to render water palatable by removing alkalis.
• Chia seeds swell in the stomach, so the person who has eaten them feels as if they have eaten a great deal — a satiety effect noted in traditional knowledge long before modern clinical investigation.

The Tarahumara (Rarámuri) people of the Sierra Madres of Mexico also maintained a strong tradition of chia consumption. Chia seeds are consumed today by the Tarahumara in a drink known as chia fresca, composed of roasted, ground seeds and water.

3. Key Chemical Constituents and Active Compounds

3.1 Macronutrient Composition (Salvia hispanica seeds)

The nutritional profile of chia seeds — applicable in broad terms to both S. hispanica and S. columbariae — is distinctive for a plant food. The seed provides approximately 33% seed oil, 21% protein, 41% total dietary fiber, and high levels of minerals such as calcium, iron, magnesium, and phosphorus.

Two tablespoons of chia seeds (1 ounce or 28 grams) contain approximately 140 calories, 4 grams of protein, 11 grams of fiber, 7 grams of unsaturated fat, 18% of the RDA for calcium, and trace minerals including zinc and copper. Chia seeds are a complete protein, containing all nine essential amino acids that cannot be made by the body.

3.2 Lipids and Omega-3 Fatty Acids

The fatty acid profile is of particular interest; it is characterized by high contents of polyunsaturated fatty acids, mainly α-linolenic acid (ALA), which accounts for approximately 60% of all fatty acids. Linoleic, oleic, and palmitic acids are found in lower amounts. Chia seeds have greater contents of omega-3 acids than flaxseed, and the ratio of omega-6 to omega-3 acids is an advantageous approximately 0.3:0.35.

The ALA found in chia must be converted into the active forms (EPA and DHA) before the body can use it, and this process is often inefficient — an important limitation when evaluating chia's omega-3 benefits relative to marine sources.

3.3 Dietary Fiber

Chia seeds contain approximately 30–34 g dietary fiber per 100 g, of which the insoluble fraction accounts for approximately 85–93%, while soluble dietary fiber is approximately 7–15%; in terms of dietary fiber content, chia seeds exceed dried fruits, cereals, or nuts.

The fiber in chia seeds is mainly insoluble fiber and mucilage — the substance responsible for the gluey texture of moistened chia seeds — which acts as a soluble fiber; these fibers may help to lower LDL cholesterol and slow down digestion, which can prevent blood sugar spikes after eating a meal and promote a feeling of fullness.

3.4 Phenolic Compounds and Antioxidants

Chia seeds contain healthy ω-3 fatty acids, polyunsaturated fatty acids, dietary fiber, proteins, vitamins, and some minerals; besides this, the seeds are an excellent source of polyphenols and antioxidants, such as caffeic acid, rosmarinic acid, myricetin, quercetin, and others.

Chia seed is a potential source of antioxidants with the presence of chlorogenic acid, caffeic acid, myricetin, quercetin, and kaempferol, which are believed to have cardiac and hepatic protective effects, as well as anti-ageing and anti-carcinogenic characteristics.

Vitamin content per 100 g chia seed includes: vitamin C, 5.4 mg; thiamine, 0.7 mg; riboflavin, 0.2 mg; niacin, 7.2 mg; vitamin B6, 0.1 mg. Antioxidant content includes caffeic acid, chlorogenic acid, quercetin, myricetin, and kaempferol.

These seeds are also a good source of many minerals and vitamins, as well as bioactive compounds of high antioxidant activity, particularly polyphenols and tocopherols.

A 100-g serving of chia provides significant amounts of magnesium, potassium, and calcium, all potent vasodilators and vascular smooth muscle contraction inhibitors; additionally, chia seeds contain flavonoids such as quercetin, chlorogenic acid, and caffeic acid, which have been shown to lower blood pressure.

3.5 Unique Constituents of Salvia columbariae: Tanshinones

A notable phytochemical distinction of Salvia columbariae compared to S. hispanica is the presence of tanshinone-class diterpenoids, compounds otherwise most associated with the Chinese medicinal herb Salvia miltiorrhiza (Danshen). A peer-reviewed study published in Evidence-Based Complementary and Alternative Medicine (Adams et al., 2005) established this finding:

Salvia columbariae was examined and found to contain miltionone II, cryptotanshinone, and tanshinone IIA; these compounds may be of interest in the treatment of stroke and heart attack. HPLC-MS analysis identified miltionone II at 2.7 min, cryptotanshinone at 6.3 min, and tanshinone IIA at 12 min in a chia root extract.

The tanshinones are abietane-type diterpenoid quinones. Tanshinone IIA, the most extensively studied member of this class from S. miltiorrhiza, has demonstrated antiplatelet, anti-inflammatory, and neuroprotective properties in preclinical research. The presence of these compounds in S. columbariae provides a possible phytochemical rationale for some traditional Chumash and Cahuilla uses, including the use of the plant in contexts associated with stroke and circulation.

3.6 Mucilage (Seed Coat Polysaccharide)

When chia seeds contact water, the outer seed coat releases a hydrocolloid polysaccharide — the mucilage — that forms the characteristic viscous gel. This mucilage is classified as a soluble dietary fiber. The seeds are hydrophilic, absorbing up to 12 times their weight in liquid when soaked; while soaking, they develop a mucilaginous coating that gives chia-based beverages a distinctive gelatinous texture. Because of their high content of soluble fiber, chia seeds can absorb up to 10–12 times their weight in water, turning thick and swelling in the stomach, which should increase satiety, moderate food ingestion, and assist in reducing calorie consumption; soluble fiber can also feed beneficial bacteria in the intestinal tract.

3.7 Protein Fractions

Chia seed sprouts have been found to exhibit increased essential amino acid content, elevated levels of dietary fiber and total phenols, and enhanced antioxidant capability. Quantified storage protein fractions reveal variation concerning nutraceutical proteins such as albumin and glutelin. Peptides derived from these protein fractions have demonstrated in vitro inhibition of angiotensin-I-converting enzyme (ACE), suggesting a potential blood pressure-lowering mechanism at the peptide level, though this remains to be confirmed in well-designed human trials.

4. Scientific Evidence by Area of Use

The following section reviews clinical and human evidence. Where evidence is limited, animal- or in-vitro-only, or inconsistent, this is stated explicitly. Most clinical research has been conducted on Salvia hispanica seeds. No clinical trials specific to Salvia columbariae seeds were identified in the literature. Given the botanical relationship and comparable seed composition, evidence from S. hispanica is presented here as the most applicable available data.

4.1 Cardiovascular Risk Factors

Blood Pressure

Multiple systematic reviews and meta-analyses have examined chia's effect on systolic and diastolic blood pressure. A comprehensive systematic review and meta-analysis examining 14 clinical trials involving 835 participants found a notable decrease in triglyceride levels across both higher and lower doses of chia seeds (weighted mean differences of −8.69 mg/dL and −13.11 mg/dL, respectively); a statistically significant decrease in systolic blood pressure of −2.78 mmHg compared to the control group was observed, but only with the higher dosage.

Another review synthesizing data from systematic reviews and meta-analyses of randomized controlled trials found that chia supplementation resulted in significant reductions in diastolic blood pressure (Hedges' g = −0.550; 95% CI: −0.718 to −0.382) and systolic blood pressure (g = −0.119; 95% CI: −0.228 to −0.010).

The Vuksan group's landmark RCT in type 2 diabetes patients, published in Diabetes Care (2007), demonstrated improvements in systolic blood pressure and inflammatory markers with supplementation of the Salba-chia variety at 37 g/day of Salba-chia added to an isocaloric diet, which improved major and emerging risk factors in type 2 diabetes, suggesting cardioprotective potential while maintaining weight.

An early systematic review covering seven clinical trials (n = 200) found mixed results: one study showed a significant drop in systolic blood pressure and inflammatory markers, yet there was no change in body mass, lipid profile, or blood sugar; in four of the studies reviewed, there was a significant spike in ALA and eicosapentaenoic acid (EPA), with no significant change to other parameters.

Evidence strength: Modest and statistically significant effects on blood pressure are reported in multiple meta-analyses, but the magnitude of reduction is small, dose-dependent, and not uniformly observed across all trials. The evidence is promising but not yet sufficient to support chia as a standalone antihypertensive intervention.

Lipid Profile

A 2024 meta-regression of 14 RCTs found a notable decrease in triglyceride levels (WMD −8.69 to −13.11 mg/dL), and a statistically significant reduction in LDL-C levels of −4.77 mg/dL, observed solely in the higher-dosage group.

However, a separate 2024 meta-analysis of 10 RCTs in overweight subjects found no significant changes in lipid profile, including triglycerides, total cholesterol, or HDL, in overweight subjects.

Evidence strength: Results on lipids are conflicting across meta-analyses. Differential effects may depend on baseline lipid levels, study duration, dose, and form of chia used. The overall lipid evidence should currently be described as preliminary and inconsistent in human populations.

4.2 Glycemic Control and Type 2 Diabetes

A meta-analysis confirmed a substantial reduction in postprandial glucose area under the curve of up to 17.3% (95% CI: −22.1 to −12.5); supporting these findings, a 24-week randomized controlled trial administering 60 g/day of ground chia seeds demonstrated a significant attenuation in the rise of HbA1c compared to a fiber-matched control, resulting in an absolute end difference of −0.27% (p = 0.03), an effect more pronounced (−0.56%) in individuals with suboptimal baseline glycemic control (HbA1c >7%).

In acute trials reviewed in a 2015 systematic review, post-prandial blood sugar was significantly lower with chia consumption.

A study by the Vuksan group demonstrated that Salba-chia acutely reduced postprandial glycemia when added to a meal, and prolonged satiety.

Evidence strength: Evidence for acute postprandial glucose reduction is relatively consistent and mechanistically plausible (mediated by mucilage-induced slowing of digestion). Evidence for long-term glycemic improvement is more limited and derived from a small number of RCTs. Additional large, long-duration trials are needed.

4.3 Body Weight and Satiety

A rigorous randomized crossover trial (n = 24) examined chia seed addition to yogurt as a mid-morning snack. Subjects were tested across three snack conditions: yogurt with no chia seed, yogurt with 7 g chia seed, and yogurt with 14 g chia seed; VAS scores indicated that participants reported significantly lower hunger, prospective food consumption, amounts of food that could be consumed, desire for sugary foods, and higher satiety on test days with 7 g and 14 g chia seed.

The effects of long-term consumption of chia seed on overweight- or obesity-related parameters remain controversial, unlike acute-term studies. Significant reductions in body weight were observed after 6 months of chia seed consumption in one study, whereas no change in body weight was reported following 12 weeks of consumption in another. Difficulties in standardization of study designs and metabolic and nutritional differences in study populations may have contributed to these results.

Further investigations demonstrated that a 6-month addition of Salba-chia to a calorie-restricted diet, in conjunction with standard medical care, resulted in small but significant weight loss in overweight and obese patients.

Evidence strength: Short-term satiety effects are supported by mechanistic plausibility and small RCT data. Long-term weight-loss effects are modest, inconsistent, and contingent on study design. Chia seeds alone cannot currently be characterized as a weight-loss intervention based on the available evidence base.

4.4 Inflammation

Chia seeds have gained significant attention due to their unique composition and potential health benefits, including high dietary fibers, omega-3 fatty acids, proteins, and phenolic compounds; these components contribute to their antioxidant and anti-inflammatory effects.

One clinical study within a 2015 systematic review showed a significant drop in inflammatory markers alongside the reduction in systolic blood pressure. However, as the authors noted, results across trials were not uniform.

Evidence strength: Anti-inflammatory effects are primarily based on the known properties of ALA (omega-3) and polyphenols found in chia. Dedicated clinical trials measuring inflammatory markers specifically are limited; evidence in this area must currently be considered preliminary.

4.5 Bone Health

Chia seeds are an unusually rich plant source of calcium: two tablespoons (28 g) provide 18% of the RDA for calcium. The seed has unique benefits of high levels of the essential fatty acid esters of ALA and LA, protein, both soluble and insoluble dietary fiber, and high levels of calcium, potassium, magnesium, and phosphorus. However, no dedicated clinical trials on chia supplementation and bone mineral density were identified in the current literature search. Evidence for bone-health effects is indirect, based on micronutrient content only.

4.6 Digestive Health

Chia fiber may also be fermented in the gut, promoting the formation of short-chain fatty acids (SCFAs) and improving colon health. Soluble fiber can also feed beneficial bacteria in the intestinal tract, which is absolutely essential for maintaining good flora nutrition and intestinal health.

Evidence strength: Mechanistic evidence for digestive benefits from mucilage and soluble fiber is well-established at the class level. Chia-specific human intervention studies targeting gut microbiome or colonic health endpoints are limited.

4.7 Tanshinone-Related Activity Specific to Salvia columbariae

Research has established that Salvia columbariae contains miltionone II, cryptotanshinone, and tanshinone IIA; these compounds may be of interest in the treatment of stroke and heart attack. Tanshinone IIA and cryptotanshinone are the same diterpenoid compounds present in the Chinese medicinal plant Salvia miltiorrhiza (Danshen), for which a substantially larger pharmacological literature exists. In the Chinese herbal tradition, these compounds have been studied for antiplatelet aggregation, anti-ischemic, and neuroprotective effects. However, no clinical trials have been conducted directly on Salvia columbariae root or seed extracts for these endpoints. The tanshinone content of S. columbariae reported in peer-reviewed literature is limited to root extracts and the amounts are lower than those found in S. miltiorrhiza. Extrapolation of clinical findings from Danshen to California chia would be premature.

5. Body Systems and Health Areas Associated with California Chia

• Cardiovascular system: Chia seed components are helpful in cardiovascular disease by reducing blood pressure, platelet aggregation, cholesterol, and oxidation.
• Metabolic/endocrine system: Evidence from RCTs supports improved postprandial glycemia and modest HbA1c attenuation in type 2 diabetes patients.
• Gastrointestinal system: Mucilage and soluble fiber contribute to intestinal motility, satiety signaling, and gut microbiome support.
• Musculoskeletal system: High calcium, magnesium, and phosphorus content provide nutrients relevant to bone metabolism; the ALA content has been associated with potential anti-inflammatory effects relevant to joints, though clinical data for chia specifically are not yet robust.
• Neurological/cerebrovascular system (preclinical only): Miltionone II, cryptotanshinone, and tanshinone IIA found in S. columbariae may be of interest in the treatment of stroke and heart attack, but this remains at the stage of phytochemical identification and has not been evaluated in clinical trials.
• Integumentary/ophthalmic (traditional use): External poultice use for infections and the seed-in-eye technique for inflammation are historical Native American practices without modern clinical evaluation.

6. Dosage Forms and Doses Reported in Studies

The following doses are reported directly from cited study data and should not be interpreted as recommended doses:

• Clinical trials have used doses of 15 to 50 g per day over 4 to 12 weeks across cardiometabolic populations.
• 37 g/day of Salba-chia supplemented to an isocaloric diet was used in the Vuksan group's type 2 diabetes RCT (published in Diabetes Care, 2007).
• 60 g/day of ground chia seeds was administered in a 24-week RCT examining HbA1c outcomes.
• 7 g and 14 g of chia seed added to yogurt were the doses tested in the satiety crossover trial.
• One serving of dried chia seeds is approximately 2.5 tablespoons, as noted by the Mayo Clinic Health System.
• One ounce of chia seeds (two to three tablespoons) provides approximately 9.8 grams of dietary fiber, according to Harvard Health.

No standardized, regulatory-approved dosing recommendation for Salvia columbariae seeds specifically has been identified in the literature reviewed. Dosing ranges from S. hispanica research are considered the closest applicable reference.

7. Safety Considerations and Drug Interactions

7.1 General Tolerability

Gastrointestinal adverse effects are the most commonly reported adverse effect in clinical studies of chia; information regarding toxicity of chia is limited.

Unlike flaxseed, chia seed contains no gluten, cyanogenic glycosides, lignans, or vitamin B antagonists, which is noted as a tolerability advantage over some other high-omega-3 plant seeds.

7.2 Esophageal Obstruction

A case report of complete distal esophageal obstruction by a gel of hydrated chia seeds has been published. This is a physical risk specific to dry seeds being swallowed without adequate water, as the mucilage expands rapidly on contact with moisture.

7.3 Anticoagulant and Antiplatelet Drug Interactions

Caution is warranted if chia is used concurrently with anticoagulants (e.g., warfarin) or antiplatelet agents (e.g., aspirin, clopidogrel, prasugrel), due to case reports of enhanced anticoagulation and bleeding with ingestion of species related to chia. Chia seeds contain high omega-3 fatty acids, which might increase the risk of bleeding; caution should be exercised when taking chia seeds with medicines, foods, or supplements having anticoagulant or antiplatelet effects.

7.4 Antihypertensive Drug Interactions

In a study, chia seeds were found to lower blood pressure in patients with type 2 diabetes who were already taking medicines for blood pressure; combining these medications with chia seeds might lead to a pronounced blood pressure-lowering effect.

7.5 Antidiabetic Drug Interactions

Due to chia seeds' potential impact on blood pressure, blood sugar, and blood thinning, there is a risk of interactions with medications, particularly antihypertensives, anticoagulants, and diabetes medications.

7.6 Allergic Reactions

Case reports of allergy to chia exist, and Salmonella-infected sprouted chia seed powder has been documented. A Salmonella-infected sprouted chia seed powder led to an outbreak of foodborne infection in the United States and Canada in 2013 and 2014. Individuals with known allergies to related seeds should exercise caution.

7.7 Pregnancy and Lactation

There is not enough data on the safe use of chia seeds during pregnancy and breastfeeding. No clinical trials have examined chia supplementation in pregnant or lactating populations.

7.8 Evidence Gaps Specific to Salvia columbariae

Essentially all clinical safety and interaction data reviewed pertain to Salvia hispanica. While S. columbariae shares the same seed mucilage, omega-3 fatty acid profile, and high-fiber composition that are the basis for most safety considerations, the tanshinone content of S. columbariae root introduces a distinct phytochemical dimension that has not been evaluated for pharmacological interactions in human subjects. No clinical trials, case reports, or systematic safety reviews specific to S. columbariae use in humans were identified in this review.

References

• Adams JD et al. "Salvia columbariae contains tanshinones." Evidence-Based Complementary and Alternative Medicine, 2005. PMC
• Teoh SL et al. "Effect of Chia Seed (Salvia hispanica L.) Consumption on Cardiovascular Risk Factors in Humans: A Systematic Review." Nutrición Hospitalaria, 2015. PubMed
• Mirmiran P et al. "The impact of chia seeds on diabetes, blood pressure, lipid profile, and obesity indicators: Systematic review and meta-regression analysis of 14 randomized controlled trials." Journal of Functional Foods, 2024. PubMed
• Al-Ozairi E et al. "Effects of chia seed (Salvia hispanica L.) supplementation on cardiometabolic health in overweight subjects: a systematic review and meta-analysis of RCTs." PMC, 2024.
• The Chemical Composition and Nutritional Value of Chia Seeds — Current State of Knowledge. PMC 2019.
• Chia Seeds (Salvia hispanica L.): An Overview — Phytochemical Profile, Isolation Methods, and Application. PMC 2020.
• Nutritional and Therapeutic Perspectives of Chia (Salvia hispanica L.): a review. PMC 2016.
• Chia seeds (Salvia hispanica L.): A therapeutic weapon in metabolic disorders. PMC 2023.
• Chia seed (Salvia hispanica L.) added yogurt reduces short-term food intake and increases satiety: randomised controlled trial. PMC 2017.
• The nutritional profile of chia seeds and sprouts: tailoring germination practices for enhancing health benefits — a comprehensive review. PubMed 2024.
• Harvard T.H. Chan School of Public Health — The Nutrition Source: Chia Seeds.
• Harvard Health Publishing: Chia seed benefits: What you need to know.
• Wikipedia: Salvia columbariae.
• Wikipedia: Chia seed.
• ScienceDirect Topics: Salvia hispanica — An Overview.
• Comparative transcriptome analysis of cultivated and wild seeds of Salvia hispanica (chia). PMC 2019.
• Drugs.com Natural Product Database: Chia Uses, Benefits & Dosage.
• Wood JRI et al. "Salvia hispanica: Lamiaceae." Curtis's Botanical Magazine, 2022. Wiley Online Library.
• UC Irvine Natural History: Salvia columbariae Benth.
• Native Seeds/SEARCH: Tarahumara Chia.
• Mayo Clinic Health System: Chia seeds pack nutritional punch.
• Fatty acids characterization, oxidative perspectives and consumer acceptability of oil extracted from pre-treated chia (Salvia hispanica L.) seeds. PMC 2017.
• Protein Digests and Pure Peptides from Chia Seed Prevented Adipogenesis and Inflammation by Inhibiting PPARγ and NF-κB Pathways in 3T3L-1 Adipocytes. PMC 2021.
• Wildflowers of Joshua Tree Country: Salvia columbariae — California Chia.
• USC Plants and People: Salvia hispanica: A Source of Strength.